Celularity Inc. (NASDAQ:CELUW) Sees Significant Increase in Short Interest

Celularity Inc. (NASDAQ:CELUW) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 174,500 shares, an increase of 5.1% from the June 30th total of 166,100 shares. Based on an average daily volume of 8,500 shares, the short-interest ratio is currently 20.5 days.

Celularity Stock Performance

Shares of NASDAQ CELUW remained flat at $0.02 during mid-day trading on Wednesday. Celularity has a one year low of $0.00 and a one year high of $0.11. The business has a 50 day moving average of $0.02 and a 200 day moving average of $0.03.

About Celularity

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.